Skip to main content
OpenTrials

Clinical trial condition

Schizophrenia Spectrum and Other Psychotic Disorders

Explore clinical trials studying Schizophrenia Spectrum and Other Psychotic Disorders. Study availability and eligibility vary by location and protocol.

3,083 public trials 347 recruiting studies
Refine in advanced search Browse all conditions

Schizophrenia Spectrum and Other Psychotic Disorders trial results

Completed

A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia

NCT00089869

Conditions
Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations
  • "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician." Cerritos, California, United States
  • "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician. Chula Vista, California, United States
  • For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Garden Grove, California, United States
  • "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician." San Diego, California, United States
View all 20 locations
View Trial Details
Completed

Pharmacokinetic Characterization of Intramuscular Olanzapine Depot

NCT00094640

Conditions
Mental Disorders, Psychotic Disorders, Schizoaffective Disorder, +2 more
Locations
  • For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Adelaide, South Australia, Australia
  • For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Kortenberg, Belgium
  • For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Rio de Janeiro, Brazil
  • For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Zagreb, Croatia
View Trial Details
Completed

The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder

NCT00044187

Conditions
Bipolar Disorder, Bipolar and Related Disorders, Mental Disorders, +4 more
Locations
  • El Centro, California, United States
  • Jacksonville, Florida, United States
  • Miami, Florida, United States
  • Boise, Idaho, United States
View all 16 locations
View Trial Details

Related conditions